SFL – Notice of Annual General Meeting 2025SFL – Notice of Annual General Meeting 2025 GlobeNewswire
||
SFL Corporation Ltd. (NYSE: SFL) (“SFL” or the “Company”) advises that the 2025 Annual General Meeting of the Company will be held on May 8, 2025. The record date... Defiance Launches $GLDY, Gold Enhanced Options Income ETFDefiance Launches $GLDY, Gold Enhanced Options Income ETF GlobeNewswire
||
Defiance Launches $GLDY, Gold Enhanced Options Income ETF Defiance ETFs is proud to announce the launch of GLDY, the Defiance Gold Enhanced Options Income ETF. MIAMI, April 02, 2025... Moringa: Learn Why These Moringa Powder Supplements Are Transforming Energy, Immunity, and Overall HealthMoringa: Learn Why These Moringa Powder Supplements Are Transforming Energy, Immunity, and Overall Health GlobeNewswire
||
LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) — Moringa Oleifera, often called the “Miracle Tree,” is rapidly gaining recognition in the U.S. as a superfood for its remarkable health... Patagonia Gold Enters Into Option Agreement With Newmont CorporationPatagonia Gold Enters Into Option Agreement With Newmont Corporation GlobeNewswire
||
VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) — Patagonia Gold Corp. (“Patagonia” or the “Company”) (TSX.V:PGDC) is pleased to announce that it has entered into a binding letter... Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric PatientQuoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient GlobeNewswire
||
Continued Clear Visual Evidence of Almost Completely Healed Skin After 6 weeks TreatmentHigh Durability of Treatment Effect of QRX003 with Continuous Daily Dosing Patient Continues Not to Require Previously... Atsena Therapeutics Announces Oversubscribed $150 Million Series C Financing to Further Advance Ocular Gene Therapy ProgramsAtsena Therapeutics Announces Oversubscribed $150 Million Series C Financing to Further Advance Ocular Gene Therapy Programs GlobeNewswire
||
Financing led by new investor Bain Capital with participation from new investor Wellington Management and all existing investors Proceeds to support advancement of ATSN-201 through potential approval and launch... Costamare Inc. Declares Quarterly Dividend on Its Preferred and Common StockCostamare Inc. Declares Quarterly Dividend on Its Preferred and Common Stock GlobeNewswire
||
MONACO, April 02, 2025 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company”) (NYSE: CMRE) has declared cash dividends of US $0.476563 per share on its 7.625% Series B Cumulative Redeemable... 
Man Group PLC : Form 8.3 – Dowlais Group plcMan Group PLC : Form 8.3 – Dowlais Group plc GlobeNewswire
||
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION... Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual ConferenceSensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference GlobeNewswire
||
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients,... Planet 13 Opens New Dispensary in Orange Park, FL, Serving Jacksonville PatientsPlanet 13 Opens New Dispensary in Orange Park, FL, Serving Jacksonville Patients GlobeNewswire
||
LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced...